Preparation and identification of anti-human ICAM-1 scFv.
- Author:
Yunyu CHEN
1
;
Chenchen ZHAO
2
;
Gang LIU
1
;
Huabo HU
1
;
Guoli ZHANG
2
;
Xiaoping LIU
1
;
Yuhuan YUE
2
Author Information
- Publication Type:Journal Article
- Keywords: ICAM-1; humanized antibody; intercellular adhesion molecule; phage display technology; scFv
- MeSH: Antibodies; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin Variable Region; Intercellular Adhesion Molecule-1; immunology; Peptide Library; Single-Chain Antibodies
- From: Chinese Journal of Biotechnology 2018;34(12):2016-2024
- CountryChina
- Language:Chinese
- Abstract: To screen the specific anti-human intercellular adhesion molecule-1 (ICAM-1) single chain fragment variable (scFv) using phage display library technology and to identify its biological activity. P1 peptide was used as antigen, and the phage antibodies against human ICAM-1 antigen were panned by four binding-eluting-amplifying cycles using Tomlinson I+J phage display library. After four rounds of selective enrichment screening, the positive clones were determined by PCR, enzyme linked immunosorbent assay (ELISA)-based antigenic cross reaction and Dot blotting. Then the binding specificity and biological activity of purified scFv were identified by Western blotting, competitive ELISA and cell adhesion inhibition assay respectively. Furthermore, four positive clones were first panned through P1 peptide coated-ELISA assay, and then J-A1 was obtained and identified by PCR, ELISA-based antigenic cross reaction and Dot blotting, which could show a specific binding between P1 peptide and human ICAM-1 protein antigen. Subsequently, the purified scFv showed a satisfactory specificity and anti-adhesive activity in competitive ELISA and the cell adhesion inhibition assay. The specific anti-human ICAM-1 scFv was prepared successfully from Tomlinson I+J phage display library, which pave the way for further application of anti-human ICAM-1 scFv for inflammation diseases therapeutics.
